As communicated on January 21, 2020, CTS will implement the licensed Grifols Babesia test for samples received on April 20, at the Charlotte, Dallas, Phoenix, St. Louis and Tampa laboratories. Babesia is a selective pooled NAT test, required for all blood donations collected by May 2020, in 14 States and the District of Columbia. To help you understand the requirements, CTS will host a Babesia Implementation and Review webinar on March 3, 2020 at 11:00 am CST. If you are interested in attending, please contact your Customer Service Manager for invitation details.
Beginning June 1, 2020 all 5 CTS laboratories will being transitioning from the Grifols Procleix Ult...
In response to the FDA guidance document for Babesia, CTS will implement the licensed Grifols ...
In 2016, the Procleix Panther instrument was introduced by Grifols in support of automated NAT ZIKA ...
CTS will be transitioning to a new sFTP server for clients who send test request and/or receive...
The COVID-19 pandemic has unveiled the huge challenges and risks health workers are facing globally ...
On December 9, 2019, the new CTS Laboratory Information System successfully implemented in Phoe...